Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Jun;103(2):1333–1338. doi: 10.1111/j.1476-5381.1991.tb09789.x

Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.

M Hirafuji 1, H Shinoda 1
PMCID: PMC1908373  PMID: 1884095

Abstract

1. Platelet-activating factor (PAF, 10 nM) did not induce platelet adhesion to endothelial cells cultured in monolayer but it induced their adhesion to protein-coated plastic. However, PAF induced a marked platelet adhesion to endothelial cells when polymorphonuclear leukocytes (PMNs) were present. Lyso-PAF had no effect. 2. Phase-contrast microscopic examination showed that single platelets rather than their aggregates adhered to the endothelial cell surface around aggregating and adhering PMNs. 3. Significant platelet adhesion was induced by PAF at concentrations higher that 0.01 nM with the maximal response at 10 nM. Platelet adhesion occurred within minutes after PAF addition, reaching a maximum approximately after 30 min. Platelet adhesion also occurred significantly at a PMN:platelet ratio of 1:800, and linearly up to 1:50. 4. The PAF-induced platelet adhesion was suppressed by three structurally unrelated PAF antagonists, WEB 2086, ONO 6240 and BN 52021, in a concentration-dependent manner. 5. PAF also increased PMN adhesion to endothelial cell monolayers, which was further augmented by the presence of platelets. 6. The present study demonstrates that PAF induces platelet adhesion to endothelial cells in vitro when PMNs are present and that there is a close interaction between platelets and PMNs in their adhesion to endothelial cells. The present study further suggests that PMNs could play a central role in platelet adhesion to vascular endothlium in certain pathological conditions.

Full text

PDF
1337

Images in this article

1335Figure 2
on p.1335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boogaerts M. A., Yamada O., Jacob H. S., Moldow C. F. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci U S A. 1982 Nov;79(22):7019–7023. doi: 10.1073/pnas.79.22.7019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourgain R. H., Vermariën H., Andries R., Vereecke F., Jacqueloot J., Rennies J., Blockeel E., Six F. A standardized 'in vivo' model for the study of experimental arterial thrombosis: description of a method. Adv Exp Med Biol. 1984;180:635–649. doi: 10.1007/978-1-4684-4895-5_62. [DOI] [PubMed] [Google Scholar]
  4. Breviario F., Bertocchi F., Dejana E., Bussolino F. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. J Immunol. 1988 Nov 15;141(10):3391–3397. [PubMed] [Google Scholar]
  5. Buchanan M. R., Haas T. A., Lagarde M., Guichardant M. 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem. 1985 Dec 25;260(30):16056–16059. [PubMed] [Google Scholar]
  6. Bussolino F., Camussi G., Aglietta M., Braquet P., Bosia A., Pescarmona G., Sanavio F., D'Urso N., Marchisio P. C. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol. 1987 Oct 1;139(7):2439–2446. [PubMed] [Google Scholar]
  7. Casals-Stenzel J., Muacevic G., Weber K. H. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther. 1987 Jun;241(3):974–981. [PubMed] [Google Scholar]
  8. Chignard M., Selak M. A., Smith J. B. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). Proc Natl Acad Sci U S A. 1986 Nov;83(22):8609–8613. doi: 10.1073/pnas.83.22.8609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clark R. A., Klebanoff S. J. Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J Immunol. 1980 Jan;124(1):399–405. [PubMed] [Google Scholar]
  10. Coëffier E., Delautier D., Le Couedic J. P., Chignard M., Denizot Y., Benveniste J. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. J Leukoc Biol. 1990 Mar;47(3):234–243. doi: 10.1002/jlb.47.3.234. [DOI] [PubMed] [Google Scholar]
  11. Coëffier E., Joseph D., Prévost M. C., Vargaftig B. B. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. Br J Pharmacol. 1987 Oct;92(2):393–406. doi: 10.1111/j.1476-5381.1987.tb11336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Curwen K. D., Kim H. Y., Vazquez M., Handin R. I., Gimbrone M. A., Jr Platelet adhesion to cultured vascular endothelial cells. A quantitative monolayer adhesion assay. J Lab Clin Med. 1982 Sep;100(3):425–436. [PubMed] [Google Scholar]
  13. Del Maschio A., Evangelista V., Rajtar G., Chen Z. M., Cerletti C., De Gaetano G. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol. 1990 Mar;258(3 Pt 2):H870–H879. doi: 10.1152/ajpheart.1990.258.3.H870. [DOI] [PubMed] [Google Scholar]
  14. Gimbrone M. A., Jr, Buchanan M. R. Interactions of platelets and leukocytes with vascular endothelium: in vitro studies. Ann N Y Acad Sci. 1982;401:171–183. doi: 10.1111/j.1749-6632.1982.tb25716.x. [DOI] [PubMed] [Google Scholar]
  15. HENRY R. L. LEUKOCYTES AND THROMBOSIS. Thromb Diath Haemorrh. 1965 Mar 15;13:35–46. [PubMed] [Google Scholar]
  16. Harlan J. M. Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions. Semin Thromb Hemost. 1987 Oct;13(4):434–444. doi: 10.1055/s-2007-1003520. [DOI] [PubMed] [Google Scholar]
  17. Heaton W. A., Heyns A. D., Joist J. H. Measurement of in vivo platelet turnover and organ distribution using 111In-labeled platelets. Methods Enzymol. 1989;169:172–187. doi: 10.1016/0076-6879(89)69058-1. [DOI] [PubMed] [Google Scholar]
  18. Higgs E. A., Moncada S., Vane J. R., Caen J. P., Michel H., Tobelem G. Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium. Prostaglandins. 1978 Jul;16(1):17–22. doi: 10.1016/0090-6980(78)90197-1. [DOI] [PubMed] [Google Scholar]
  19. Hirafuji M., Maeyama K., Watanabe T., Ogura Y. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor. Biochem Biophys Res Commun. 1988 Aug 15;154(3):910–917. doi: 10.1016/0006-291x(88)90226-4. [DOI] [PubMed] [Google Scholar]
  20. Hirafuji M., Mencia-Huerta J. M., Benveniste J. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. Biochim Biophys Acta. 1987 Oct 1;930(3):359–369. doi: 10.1016/0167-4889(87)90009-7. [DOI] [PubMed] [Google Scholar]
  21. Issekutz A. C., Ripley M., Jackson J. R. Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest. 1983 Dec;49(6):716–724. [PubMed] [Google Scholar]
  22. Levine P. H., Weinger R. S., Simon J., Scoon K. L., Krinsky N. I. Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J Clin Invest. 1976 Apr;57(4):955–963. doi: 10.1172/JCI108372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McGregor D. H., Davis J. W., Liu P. I., Gates E., Poindexter A. R. Platelet satellitism: experimental studies. Lab Invest. 1980 Mar;42(3):343–355. [PubMed] [Google Scholar]
  24. Oda M., Satouchi K., Yasunaga K., Saito K. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J Biochem. 1986 Nov;100(5):1117–1123. doi: 10.1093/oxfordjournals.jbchem.a121815. [DOI] [PubMed] [Google Scholar]
  25. Radomski M. W., Palmer R. M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987 Nov 7;2(8567):1057–1058. doi: 10.1016/s0140-6736(87)91481-4. [DOI] [PubMed] [Google Scholar]
  26. Rasp F. L., Clawson C. C., Repine J. E. Platelets increase neutrophil adherence in vitro to nylon fiber. J Lab Clin Med. 1981 Jun;97(6):812–819. [PubMed] [Google Scholar]
  27. Salvemini D., de Nucci G., Sneddon J. M., Vane J. R. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol. 1989 Aug;97(4):1145–1150. doi: 10.1111/j.1476-5381.1989.tb12572.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shaw J. O., Henson P. M. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. Am J Pathol. 1980 Mar;98(3):791–810. [PMC free article] [PubMed] [Google Scholar]
  29. Sneddon J. M., Vane J. R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2800–2804. doi: 10.1073/pnas.85.8.2800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Snyder F. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev. 1985 Jan-Mar;5(1):107–140. doi: 10.1002/med.2610050105. [DOI] [PubMed] [Google Scholar]
  31. Zimmerman G. A., McIntyre T. M., Prescott S. M. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest. 1985 Dec;76(6):2235–2246. doi: 10.1172/JCI112232. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES